Results 81 to 90 of about 1,717 (156)

Nocardiosis pulmonar tratada con tedizolid

FARMACIA HOSPITALARIA, 2019
Giménez Arufe, Víctor, Gutierrez Urbon, José, Blanco Aparicio, Marina, Míguez Rey, Enrique, Martín Herranz, Isabel   +4 more
openaire   +3 more sources

Advances in Therapeutic Drug Monitoring and Pharmacokinetic Researches of Oxazolidinone Antibacterial Agents in the Elderly Patients. [PDF]

Clin Interv Aging
Liu T, Li Z, Wei G, Yang Y, Wang F, Wang Y, Kang K, Yang P, Li H, Liu B, Fang X.   +10 more
europepmc   +1 more source

Optimizing Tedizolid Dosing in Cerebral Nocardiosis: Clinical Impact of Direct Unbound Concentration Measurement and Population PK Modelling in Two Cases. [PDF]

JAC Antimicrob Resist
Marc-Olivier V, Margaux B, David L, Anne Christine J, Heidi W, Christophe A, Laure A, Alexia C.   +7 more
europepmc   +1 more source

Health Technology Assessment of Oxazolidinones for MRSA-Associated Complicated Skin and Soft Tissue Infections. [PDF]

Drug Des Devel Ther
Zhao Y, Huang B, Yang Z, Kuang H, Chen J.   +4 more
europepmc   +1 more source

Trends in Linezolid Prescription in Japan based on National database open Data: implications for the need for therapeutic drug monitoring. [PDF]

J Pharm Health Care Sci
Muraki Y, Ohmagari N.
europepmc   +1 more source

Insufficient cerebrospinal fluid penetration of tedizolid: a case report. [PDF]

JAC Antimicrob Resist
Brousse X, Lê MP, Lahouati M, Petitgas P.   +3 more
europepmc   +1 more source

Linezolid-related Optic Nerve Disorders: Insight From a Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System. [PDF]

Open Forum Infect Dis
Nakano Y, Miyazaki M, Fukuyama A, Hasuwa H, Imakyure O.   +4 more
europepmc   +1 more source

Resistance mechanisms and tedizolid susceptibility in clinical isolates of linezolid-resistant bacteria in Japan. [PDF]

JAC Antimicrob Resist
Shoji R, Maeda M, Yamaguchi K, Takuma T, On R, Ugajin K, Okatomi D, Fukuchi K, Tokimatsu I, Ishino K.   +9 more
europepmc   +1 more source

How to use novel antimicrobials beyond official indications: an expert consensus. [PDF]

JAC Antimicrob Resist
Retamar-Gentil P, Alegre-Albendea M, Valiente De Santis L, Castón-Osorio JJ, Márquez-Gómez I, Corzo-Delgado JE, Praena-Segovia J, Herrero-Rodríguez C, Esteban-Moreno MÁ, Martín-Aspas A, Jiménez-Aguilar P, Martínez-Marcos FJ, López-Cárdenas S, Ojeda-Burgos G, Sadyrbaeva-Dolgova S, Anguita-Santos F, Rodríguez Baño J, Palacios-Baena ZR.   +17 more
europepmc   +1 more source

Omadacycline for the treatment of acute bacterial skin and skin structure infections: a systematic review and network meta-analysis. [PDF]

BMC Infect Dis
Kong WQ, Shu YF, Tang J, Li SQ, Zhong H, Zhang XY.   +5 more
europepmc   +1 more source